日本の放射性医薬品市場レポート：製品タイプ、用途、最終用途、地域別、2025年～2033年

日本の放射性医薬品の市場規模は2024年に2億5,580万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに6億2,920万米ドルに達し、2025～2033年の成長率（CAGR）は9.73％になると予測しています。がん、心血管疾患、神経疾患などの慢性疾患の有病率の上昇が、診断・治療用放射性医薬品の需要増につながっており、市場を牽引しています。

本レポートで扱う主な質問

• 日本の放射性医薬品市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本の放射性医薬品市場に与えた影響は？
• 日本の放射性医薬品市場の製品タイプ別区分は？
• 日本の放射性医薬品市場の用途別区分は？
• 日本の放射性医薬品市場の最終用途別の区分は？
• 日本の放射性医薬品市場のバリューチェーンにおける様々なステージとは？
• 日本の放射性医薬品の主な促進要因と課題は何か？
• 日本の放射性医薬品市場の構造と主要プレーヤーは？
• 日本の放射性医薬品市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の放射性医薬品市場：イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の放射性医薬品市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本の放射性医薬品市場：製品タイプ別の内訳

• 診断用核医学
• 治療用核医学

第7章 日本の放射性医薬品市場：用途別の内訳

• 腫瘍学
• 心臓病学
• 神経学
• 内分泌学
• その他

第8章 日本の放射性医薬品市場：最終用途別の内訳

• 病院と診療所
• 研究機関
• 診断センター

第9章 日本の放射性医薬品市場：競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の放射性医薬品市場：業界分析

• 促進要因、抑制要因、機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan radiopharmaceuticals market size reached USD 255.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 629.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.73% during 2025-2033. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions that has led to an increased demand for diagnostic and therapeutic radiopharmaceuticals, is driving the market.

Radiopharmaceuticals are specialized drugs that contain a radioactive component, typically a small amount of a radioactive isotope, combined with a biologically active molecule. They are used in nuclear medicine for diagnostic and therapeutic purposes. In diagnostic applications, radiopharmaceuticals are administered to patients, and their radioactive emissions are detected using imaging equipment like gamma cameras or PET scanners. This allows healthcare professionals to visualize and assess various physiological processes within the body, such as blood flow, organ function, or the presence of specific diseases like cancer. Radiopharmaceuticals can also be used in therapeutic applications to treat certain medical conditions, such as thyroid disorders and some types of cancer. In these cases, the radioactive component is targeted to specific cells or tissues to deliver a localized dose of radiation, which can destroy or control the growth of abnormal cells. Overall, radiopharmaceuticals play a crucial role in modern medicine by providing valuable information for diagnosis and offering effective treatment options for specific diseases, all while minimizing radiation exposure to surrounding healthy tissues.

Japan Radiopharmaceuticals Market Trends:

The radiopharmaceuticals market in Japan is experiencing robust growth due to several key drivers. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has propelled the demand for diagnostic and therapeutic radiopharmaceuticals. Additionally, the growing aging population in Japan has augmented the need for advanced diagnostic tools, further fueling market expansion. Moreover, technological advancements in radiopharmaceutical production and imaging techniques have made these agents safer and more effective, boosting their adoption rates among healthcare providers. Furthermore, a rising awareness among both healthcare professionals and patients about the benefits of early disease detection and targeted therapy has contributed to the market's growth. Collaborative efforts between pharmaceutical companies and research institutions to launch novel radiopharmaceuticals have also propelled market expansion. Furthermore, the expanding application of radiopharmaceuticals in personalized medicine and their potential for precision treatment strategies, which have opened up new avenues for market development, is expected to drive the market in Japan in the coming years.

Japan Radiopharmaceuticals Market Segmentation:

Product Type Insights:

• Diagnostic Nuclear Medicine
• Therapeutic Nuclear Medicine

Application Insights:

• Oncology
• Cardiology
• Neurology
• Endocrinology
• Others

End Use Insights:

• Hospitals and Clinics
• Research Institutes
• Diagnostic Centers

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan radiopharmaceuticals market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan radiopharmaceuticals market?
• What is the breakup of the Japan radiopharmaceuticals market on the basis of product type?
• What is the breakup of the Japan radiopharmaceuticals market on the basis of application?
• What is the breakup of the Japan radiopharmaceuticals market on the basis of end use?
• What are the various stages in the value chain of the Japan radiopharmaceuticals market?
• What are the key driving factors and challenges in the Japan radiopharmaceuticals?
• What is the structure of the Japan radiopharmaceuticals market and who are the key players?
• What is the degree of competition in the Japan radiopharmaceuticals market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Radiopharmaceuticals Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Radiopharmaceuticals Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Radiopharmaceuticals Market - Breakup by Product Type

• 6.1 Diagnostic Nuclear Medicine
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Therapeutic Nuclear Medicine
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)

7 Japan Radiopharmaceuticals Market - Breakup by Application

• 7.1 Oncology
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Cardiology
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Neurology
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Endocrinology
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Radiopharmaceuticals Market - Breakup by End Use

• 8.1 Hospitals and Clinics
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Research Institutes
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Diagnostic Centers
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)

9 Japan Radiopharmaceuticals Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Radiopharmaceuticals Market - Industry Analysis

• 11.1 Drivers, Restraints and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix